Skip to main content
SpringerLink
Log in

Pathophysiologie

  • Chapter
Benigne Prostatahyperplasie

  • 61 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • 1. Aumüller, G. (1994) Molekulare Mechanismen bei der Regulation des Prostatawachstums und der Entstehung der benignen Prostatahyperplasie. NBP 3: 53-59

    Google Scholar 

  • 2. Aumüller G (1992a) Funktionelle Anatomie der Prostata. In: Vahlensieck W, Rutishauser G (Hrsg) Benigne Prostatopathien. Thieme, Stuttgart, S 4-17

    Google Scholar 

  • 3. Aumüller G (1992b) Untersuchungen zur Pathogenese der Altersprostatitis. In: Vahlensieck W, Rutishauser G (Hrsg) Benigne Prostatopathien. Thieme, Stuttgart New York, S 28-34

    Google Scholar 

  • 4. Aumüller G (1992c) BPH und Wachstumsfaktoren: Mechanismen und Hypothesen. Urologe A 31: 159-165

    Google Scholar 

  • 5. Aumüller G, Goebel HW, Bacher M, Eicheler W, Rausch U (1993) Aktuelle morphologische und funktionelle Aspekte der Prostata. Verh Dtsch Ges Pathol 77:1-18

    Google Scholar 

  • 6. Bartsch G, Rohr H-P (1982) Stereology - a new method to assess normal and pathological growth of the prostate. In: Jacobi E, Hohenfellner R (eds) Prostate cancer. International perspectives in urology, 3. Williams & Wilkins, Baltimore, pp 433-459

    Google Scholar 

  • 7. Benz M, Giefer T, Bierhoff E et al. (1993). Morphologische Klassifikation und Vergleich der unterschiedlichen Stromaknotentypen in der hyperplastischen Prostata. Verh Dtsch Ges Pathol 77: 111-116

    Google Scholar 

  • 8. Bonkhoff H, Remberger K (1993a) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat 422: 35-38

    Google Scholar 

  • 9. Bonkhoff H, Remberger K (1993b) Neue Aspekte zur Histogenese von Hyperplasien und Karzinomen der Prostata. Verh Dtsch Ges Pathol 77: 31-39

    Google Scholar 

  • 10. Bonkhoff H, Stein U, Remberger K (1994) Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25:42-46

    Google Scholar 

  • 11. Bonkhoff H, Stein U, Remberger K (1996) The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118

    Google Scholar 

  • 12. Bonkhoff H, Stein U, Remberger K (1996) Endocrine-paracrine cell types in the prostate and prostatic adenocarcinomas are postmitotic cells. Hum Pathol 26:167-170

    Google Scholar 

  • 13. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98-106

    Google Scholar 

  • 14. Bostwick DG (1992) Prostatic intraepithelial neoplasia (PIN). Current concepts. J Cell Biochem 16 H: 10-19

    Google Scholar 

  • 15. Bostwick DG (1995) High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 75:1823-1836

    Google Scholar 

  • 16. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS (1993a) Architectural patterns of highgrade prostatic intraepithelial neoplasia. Hum Pathol 24: 298-301

    Google Scholar 

  • 17. Bostwick DG, Srigley J, Grignon D et al. (1993b) Atypical adenomatosus hyperplasia of prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 24: 819-832

    Google Scholar 

  • 18. Brolin J, Skoog L, Ekman P (1992) Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissue. Prostate 20: 281-295

    Google Scholar 

  • 19. Cheville JC, Bostwick DG (1995) Prostatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol 19:1068-1076

    Google Scholar 

  • 20. Costa P, Robert M, Sarrazin B, Mottet N, Navratil H (1993) Quantitative topographic distribution of epithelial and mesenchymal components in benign prostatic hypertrophy. Eur Urol 24:120-123

    Google Scholar 

  • 21. Cunha GR, Donjacour AA, Sugimura Y (1996) Stromal-epithelial interactions and heterogeneity of proliferative activity within the prostate. Biochem Cell Biol 64: 608-614

    Google Scholar 

  • 22. Devaraj LT, Bostwick DG (1993) Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed Classification of basal cell proliferation. Am J Surg Pathol 17:645-659

    Google Scholar 

  • 23. Dhom G (1979) Frühe neoplastische Veränderungen der Prostata. Verh Dtsch Ges Pathol 63: 218-231

    Google Scholar 

  • 24. Dhom G (1991) Prostata. In: Doerr W, Seifert G (Hrsg) Pathologie des männlichen Genitale, Bd 21: Spezielle pathologische Anatomie. Springer, Berlin Heidelberg New York, S 455-642

    Google Scholar 

  • 25. Eklöv S, Funa K, Nodgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S (1993) Lack of the latent transforming growth factor beta binding protein in malignant but not benign prostatic tissue. Cancer Res 53: 3193-3197

    Google Scholar 

  • 26. Elbadawi A (1980) Benign proliferative lesions of the prostate gland. In: Spring-Mills E, Hafez ESE (eds) Male accessory sex glands. Biology and pathology. Elsevier North Holland Biomedical Press, pp 387-408

    Google Scholar 

  • 27. Epstein JI (1994) Adenosis vs atypical adenomatous hyperplasia (AAH) of the prostate. Am Surg Pathol18:1070-1071

    Google Scholar 

  • 28. Epstein JI (1995) Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to Carcinoma. Pathol Res Pract 191: 888-898

    Google Scholar 

  • 29. Gaudin PB, Epstein JI (1994) Adenosis of the prostate. Histologie features in transurethral resection speeimens. Am J Surg Pathol 18:863-870

    Google Scholar 

  • 30. Gaudin PB, Epstein JI (1995) Adenosis of the Prostate. Histologie features in needle biopsy speeimens. Am J Surg Pathol 19: 737-747

    Google Scholar 

  • 31. Gleason PE, Jones JA, Regan JS et al. (1993) Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 149: 1586-1592

    Google Scholar 

  • 32. Harper ME, Goddard L, Glynne-Jones E, Wilson DW, Price-Thomas M, Peeling WB, Griffiths K (1993) An immunhistochemical analysis of TGF-alpha-expression in benign and malignant prostatic tumors. Prostate 23:9-23

    Google Scholar 

  • 33. Helpap B (1983) Morphologie der Prostatahyperplasie. In: Helpap B, Senge TH, Vahlensieck W (Hrsg) Die Prostata, Bd 1: Prostatahyperplasie. Pharm und Medical Inform, Frankfurt, S 31-55

    Google Scholar 

  • 34. Helpap B (1991) Atypical hyperplasia, intraepithelial neoplasia, and incidental Carcinoma of the prostate. In: Altwein J, Faul P, Schneider W (eds) Incidental Carcinoma of the prostate. Springer, Berlin Heidelberg New York, S 74-91

    Google Scholar 

  • 35. Helpap B (1992a) Pathology of benign prostatic hyperplasia (BPH). In: Vahlensieck W, Rutishauser G (eds) Benign prostate diseases. Thieme, Stuttgart New York, pp 84-97

    Google Scholar 

  • 36. Helpap B (1992b) Pathology of chronic non-speeifie Prostatitis. In: Vahlensieck W, Rutishauser G (eds) Benign prostate diseases. Thieme, Stuttgart New York, pp 33-48

    Google Scholar 

  • 37. Helpap B (1995) Anatomie und Physiologie der Prostata sowie pathologische Anatomie und Pathophysiologie der BPH. In: Sökeland J (Hrsg) Benigne Prostatahyperplasie, Bd 3. Thieme, Stuttgart New York, S 1-27

    Google Scholar 

  • 38. Helpap B (1994) Histological and immunhistochemical study of chronic prostatic inflammation with and without benign prostatic hyperplasia. J Urol Pathol 2:49-64

    Google Scholar 

  • 39. Helpap B, Riede C (1995) Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic Carcinoma. Pathol Res Pract 191: 381-390

    Google Scholar 

  • 40. Helpap B, Thomas B (1995) Benigne Prostatahyperplasie (BPH) und Prostatitis. Eine histomorphologische und zellkinetische Analyse. Akt Urol 26:235-240

    Google Scholar 

  • 41. Helpap B, Oehler U, Weisser H, Bach D, Ebeling H (1995) Morphology of benign prostatic hyperplasia after treatment with sabal extract IDS 89 or placebo. J Urol Pathol 3:175-182

    Google Scholar 

  • 42. Helpap BGT, Bostwick DG, Montironi R (1995) The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate Carcinoma. An update. Virchows Arch 426:425-434

    Google Scholar 

  • 43. Holterhus PM, Zhao GQ, Aumüller G (1993) Effects of androgen deprivation and estrogen treatment on the strueture and protein expression of the rat coagulating gland. Anat Ree 235:223-232

    Google Scholar 

  • 44. Kastendieck H (1977) Ultrastruktur-Pathologie der menschlichen Prostatadrüsen. Progress in Pathology 106:1-167

    Google Scholar 

  • 45. Kastendieck H (1980) Correlations between atypical primary hyperplasia and carcinomas of the prostate. A histological study of 180 total prostatectomies. Pathol Res Pract 169: 366-387

    Google Scholar 

  • 46. Kastendieck H (1984) Klassifikation, Morphologie und Pathogenese des inzidenten Prostatacarcinoms. In: Helpap B, Senge T, Vahlensieck W (Hrsg) Die Prostata, Bd 2: Prostatacarcinom. Pharm und Medical Inform Frankfurt 133-164

    Google Scholar 

  • 47. Kastendieck H (1991) Morphological features and problems of incidental prostatic Carcinoma. In: Altwein J, Faul P, Schneider W (eds) Incidental Carcinoma of the prostate. Springer, Berlin Heidelberg New York, pp 46-55

    Google Scholar 

  • 48. Kastendieck H (1993) Pathology of prostatic Carcinoma - new approaches to its development an biological significance. Verh Dtsch Ges Pathol 77:40-69

    Google Scholar 

  • 49. Kastendieck H, Helpap B (1989) Prostatic dysplasia/atypical hyperplasia. Terminology, pathobiology, and significance. Urology [Suppl] 34:28-42

    Google Scholar 

  • 50. Konishi N, Nakaoka S, Hiasa Y, Kitahori Y, Oshima M, Samma S, Okajima E (1993) Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate Carcinoma and the relationship to efficacy of endorcrine therapy. Oncology 50:259-263

    Google Scholar 

  • 51. Loy V, Hübotter R, Bauer HW (1988) Die Entzündung, ein Wachstumsreiz der benignen Hyperplasie der Prostata. In: Bauer HW (Hrsg) Benigne Prostatahyperplasie. Klinische und experimentelle Urologie 19. Zuckschwerdt, München, S 3-12

    Google Scholar 

  • 52. MacGrogan D, Saint-Andre JP, Dicou E (1992) Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic cell lines. J Neurochem 59:1381-1391

    Google Scholar 

  • 53. McNeal JE (1983a) Relationship of the origin benign prostatic hypertrophy to prostatic structure of man and other mammals. In: Hinman F jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 152-166

    Google Scholar 

  • 54. McNeal JE (1983b) The prostate gland. Morphology and pathobiology. Monogr Urol 4: 3-33

    Google Scholar 

  • 55. McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12:619-633

    Google Scholar 

  • 56. McNeal JE (1990) Pathology of benign prostate hyperplasia. Urol Clin North Amer 17:477-486

    Google Scholar 

  • 57. Mellon K, Thompson S, Charlton RG et al. (1992) P53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147:496-499

    Google Scholar 

  • 58. Montironi R, Muzzonigro G, Magi Galluzzi C, Giannulis I, Diamanti L, Polito M (1994) Effect of LHRH agonist and flutamide (combination endocrine therapy) on the frequency and location of proliferating cell nuclear antigen and apoptotic bodies in prostatic hyperplasia J Urol Pathol 2: 161-171

    Google Scholar 

  • 59. Mostofi FK, Price EB (1973) Tumors of the male genital system. Atlas of tumor pathology. See Ser Fase 8 Washington AFIP

    Google Scholar 

  • 60. Mostofi FK, Sesterhenn J, Sobin LH (1980) Histological typing of prostate tumours. International histological Classification of tumours. No 22. World Health Organisation, Geneva

    Google Scholar 

  • 61. Pflug BR, Onoda M, Lynch JH, Djakiew D (1992) Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic tumor cell lines. Cancer Res 52: 5403-5406

    Google Scholar 

  • 62. Sakamoto N, Tsuneyoshi M, Enjoji M (1991) Sclerosing adenosis of the prostate, histopathologie and immunohistochemical analysis. Am J Surg Pathol 15: 660-667

    Google Scholar 

  • 63. Shapiro E, Becich MJ, Hartanto V, Lepor H (1992) The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol 147: 1293-1297

    Google Scholar 

  • 64. Steiner G, Gessl A, Kramer G, Schöllhammer A, Förster O, Marberger M (1994) Phenotype and funetion of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia (BPH). J Urol 151: 480-484

    Google Scholar 

  • 65. Steiner MS (1993) Role of peptide growth factors in the prostate: a review. Urology 42: 99-110

    Google Scholar 

  • 66. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK (1993) Influence of transforming growth factor beta-1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate derived fibroblasts. Prostate 22:183-197

    Google Scholar 

  • 67. Tannenbaum, Olsson CK (1983) Surgical pathology of benign prostatic hyperplasia. In: Hinmann F jr (ed) Benign prostatic hyperplasia. Springer, Berlin Heidelberg New York, pp 63-72

    Google Scholar 

  • 68. Theyer G, Kramer G, Assmann I et al. (1992) Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab Invest 66: 96-107

    Google Scholar 

  • 69. Vogel J, Bierhoff E, Pfeiffer U, Vahlensieck W (1992) Neuere Überlegungen und Untersuchungen zur benignen Prostatahyperplasie (BPH). In: Vahlensieck W, Rutishauser G (Hrsg) Benigne Prostatopathien. Thieme, Stuttgart New York, S 101-112

    Google Scholar 

  • 70. Yang Y, Chisholm GD, Habib FK (1993) Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationship with tissue androgen levels. Br J Cancer 67: 152-155

    Google Scholar 

  • 71. Zhao GQ, Holterhus PM, Dammshäuser I, Hoffbauer G, Aumüller G (1992) Estrogen induced morphological and immunohistochemical changes in stroma and epithelium of rat ventral prostate. Prostate 21:183-199

    Google Scholar 

  • 72. Franks LM (1954) Atrophy and hyperplasia in the prostate proper. J. Pathol Bact 68:617-622

    Google Scholar 

  • 73. Helpap B, Oehler U, Köllermann J (1996) Erfahrungen aus dem Konsiliardienst für Prostataerkrankungen. Pathologe 17:417-424

    Google Scholar 

  • 74. Helpap B (1996) Pathologie und Pathogenese der benignen Prostatahyperplasie (BPH) Niere, Blase, Prostata 1:4-13

    Google Scholar 

  • 75. Helpap B (1997) Prostata. In Remmele W (Hrsg) Pathologie 5 Springer Berlin, Heidelberg, New York pp 68-94

    Google Scholar 

  • 1. Albert JD, Geller J, Liui JD, Faber LE (1984) Tamoxifen decreases progesterone and nuclear androgen receptors in the human prostate. J Steroid Biochem 21:659-662

    Google Scholar 

  • 2. Anderson KM, Liao S (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature (London) 219:277-279

    Google Scholar 

  • 3. Bartsch W, Becker H, Pinkenburg FA, Krieg M (1979) Hormone blood levels and their interrelationships in normal men and men with benign prostatic hyperplasia (BPH). Acta Endocrinol (Copenh) 90: 727-736

    Google Scholar 

  • 4. Bartsch W, Krieg M, Becker H, Mohrmann H, Voigt KD (1982) Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate. Acta Endocrinol (Copenh) 100:634-640

    Google Scholar 

  • 5. Bartsch G, Keen F, Daxenbichler G et al. (1987a) Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic prostates. J Urol 137:559-564

    Google Scholar 

  • 6. Bartsch G, Decristofero A, Schweikert HU (1987b) Pseudovaginal perineoscrotal hypospadias. Clinical, endocrinological and biochemical characterization of a patient. Eur Urol 13: 386-389

    Google Scholar 

  • 7. Bartsch G, Brüngger A, Schweikert HU, Hintner H, Höpfl R, Rohr HP (1994) Benign prostatic hyperplasia: morphometric studies in relation to the hormone sensitivity of stromal tissue. In: Kurth K, Newling DWW (eds) Benign prostatic hyperplasia. Recent progress in clinical research and practice. Wiley-Liss, New York, pp 51-65

    Google Scholar 

  • 8. Bashirelahi N, O’Toole HH, Young JD (1976) A specific 17ß-estradiol receptor in human benign prostatic hypertrophy. Biochem Med 15:254-261

    Google Scholar 

  • 9. Bashirelahi N, Young JD, Sidh SM, Sanefuji H (1980) Androgen, oestrogen and progesterone and their distribution in epithelial and stromal cells of human prostate. In: Schröder FH, de Voogt HJ (eds) Steroid receptors, metabolism and prostatic cancer. Excerpta Medica, Amsterdam, pp 240-255

    Google Scholar 

  • 10. Belis JA (1980) Methodological basis for the radioimmunoassy of endogenous steroids in human prostatic tissues. Invest Urol 17: 332-336

    Google Scholar 

  • 11. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474-479

    Google Scholar 

  • 12. Berry SJ, Coffey DS, Strandberg JD, Ewing LL (1986) Effects of age, castration and testosterone replacement on the development and restoration of canine prostatic hyperplasia. Prostate 9: 295-302

    Google Scholar 

  • 13. Bolton J, Lahtonen R, Hammond GL, Vihko R (1981) Distribution and concentrations of androgens in epithelial and stromal compartments of the human benign hypertrophic prostate. J Endocrinol 90:125-131

    Google Scholar 

  • 14. Bolton NJ, Lukkarinen 0, Vihko R (1986) Concentration of androgens in human benign prostatic hypertrophic tissues incubated for up to three days. Prostate 9:159-167

    Google Scholar 

  • 15. Breiner M, Romalo G, Schweikert HU (1986) Inhibition of androgen receptor binding by natural and synthetic Steroids in cultured human genital skin fibroblasts. Klin Wochenschr 64: 732-737

    Google Scholar 

  • 16. Brodie AM, Son C, King DA, Meyer KM, Inkster SE (1989) Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydoxyandrostenedione and other inhibitors on androgen metabolism. Cancer Res 49:6551-6555

    Google Scholar 

  • 17. Bruchovsky N, Wilson JD (1968a) The conversion of testosterone to 5a-androstan-17ß-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 243: 2012-2021

    Google Scholar 

  • 18. Bruchovsky N, Wilson JD (1968b) The intranuclear binding of testosterone and 5a-androstan-17ß-ol-3-one by rat prostate. J Biol Chem 243: 5953-5960

    Google Scholar 

  • 19. Bruchovsky N, Rennie PS, Frederick HB, Goldenberg SL, Fletcher T, McLoughlin MG (1988) Kinetic parameters of 5cx-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J Clin Endocrinol Metab 67: 806-816

    Google Scholar 

  • 20. Bruchovsky N, Sadar MD, Akakura K, Goldenberg SL, Matsuoka K, Rennie PS (1996) Characterization of 5a-reductase gene expression in stroma and epithelium of human prostate. J Steroid Biochem Molec Biol 59: 397-404

    Google Scholar 

  • 21. Comaru-Schally AM, Brannan W, Schally AV, Colcolough M, Monga M (1998) Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia. J Clin Endocrinol Metab 83: 3826-3831

    Google Scholar 

  • 22. Cowan, RA, Cowan SK, Grant JK, Eider HY (1977) Biochemical investigations of separated epithelium and stroma from benign hyperplastic prostatic tissue. J Endocrinol (Oxf) 74:111-120

    Google Scholar 

  • 23. DeKlerk DP, Coffey DS, Ewing LL et al. (1979) Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. Clin Invest 64: 842-849

    Google Scholar 

  • 24. Ekman P (1983) Treatment (of BPH) with cyproterone acetate and / or bromocryptine. In: Hinman F (ed) Prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 271-276

    Google Scholar 

  • 25. Ekman P, Barrack ER, Walsh PC (1982) Simultaneous measurement of progesterone and androgen receptors in human prostate: a microasay. J Clin Endocrinol Metab 55:1089-1099

    Google Scholar 

  • 26. Ekman P, Barrack ER, Greene GL, Jensen EV, Walsh PC (1983) Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab 57:166-176

    Google Scholar 

  • 27. Gabrilove JL, Levine AC, Kirschenbaum A, Droller M (1987) Effects of a GnRH analog (leuprolide) on benign prostatic hypertrophy. J Clin Endocrinol Metab 64:1331-1333

    Google Scholar 

  • 28. Gabrilove JL, Levine AC, Kirschenbaum A, Droller M (1989) Effects of a long-acting gonadotropin-releasing hormone analog (leuprolide) therapy on prostatic size and symptoms in 15 men with benign prostatic hypertrophy. J Clin Endocrinol Metab 69: 629-632

    Google Scholar 

  • 29. Geller J (1995) Five year followup of patients with benign prostatic hyperplasiea treated with finasteride. Eur Urology 21: 267-273

    Google Scholar 

  • 30. Geller J, Albert J, Lopez D, Geller S, Niwayama G (1976) Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate. J Clin Endocrinol Metab 43: 686-688

    Google Scholar 

  • 31. Gloyna RE, Wilson JD (1969) A comparative study of the conversion of testosterone to 17ßhydroxy-5a-androstan-3-one (dihydrotestosterone) by prostate and epididymis. J Clin Endocrinol 29:970-977

    Google Scholar 

  • 32. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M (1998) The androgen receptor gene mutation database. Nucleic Acids Res 26: 234-238

    Google Scholar 

  • 33. Grayhack JT, Sadlowski RW (1975) Results of surgical treatment of benign prostatic hyperplasia. In: Grayhack JT, Wilson JD, Sherbenske MJ (eds) Benign prostatic hyperplasia. DHEW Publication No (NIH) 76-1113, US Government Printing Office, Washington DC,pp 125-134

    Google Scholar 

  • 34. Griffiths K, Cockett ATK, Coffey D et al. (1998) Regulation of prostatic growth. In: Denis L, Griffiths K, Khoury S, Cockett ATK et al. (eds). 4th International Consultation on Benign Prostatic Hyperplasia (BPH). Health Publication, Plymbridge Distributors Ltd, Plymouth, UK, pp 85-128

    Google Scholar 

  • 35. Habenicht UF, Schwarz K, Schweikert HU, Neumann F, El Etreby MF (1986) Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results. Prostate 8: 181-194

    Google Scholar 

  • 36. Habenicht UF, Schwarz K, Neumann F, El Etreby MF (1987) Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (macaca fascicularis) and its antagonization by the aromatase inhibitor l-methyl-androsta-l,4-diene-3,17-dione. Prostate 11: 313-326

    Google Scholar 

  • 37. Habib FK (1994) The role of growth factors in the pathogenesis of BPH. In: Kurth K, Newling DWW (eds) Benign prostatic hyperplasia. Recent progress in clinical research and practice. Wiley-Liss, New York, pp 43-50

    Google Scholar 

  • 38. Habib FK, Lee SR, Stretch SR, Smith PH (1976) Androgen levels in the plasma and prostatic tissue of patients with benign hypertrophy and Carcinoma of the prostate. J Endocrinol 71:99-107

    Google Scholar 

  • 39. Hammond GL (1978) Endogenous Steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues. J Endocrinol 78: 7-19

    Google Scholar 

  • 40. Harper ME, Pike E, Peeling WB, Griffiths K (1974) Steroids of adrenal origin metabolized by human prostatic tissue both in vitro and in vivo. J Endocrinol 60:117-125

    Google Scholar 

  • 41. Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S, Sasano H (1997) Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 31:118-124

    Google Scholar 

  • 42. Huggins C, Stevens RA (1940) The effect of castration on benign hypertrophy of the prostate in man. J Urol 43: 705-714

    Google Scholar 

  • 43. Imperator-McGinley J, Gautier T, Zirinsky K et al. (1992) Prostate visualization studies in males homozygous and heterozygous for 5<x-reductase deficiency. J Clin Endocrinol Metab 75: 1022-1026

    Google Scholar 

  • 44. Isaacs JT, Coffey DS (1981) Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia. Endocrinology 108:445-453

    Google Scholar 

  • 45. Isaacs JT, Brendler CB, Walsh PC (1983) Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab 56:139-146

    Google Scholar 

  • 46. Kaburagi Y, Marino MB, Kirdani RY, Greco JP, Karr JP, Sandberg AA (1987) The possibility of aromatization of androgen in human prostate. J Steroid Biochem 26:739-742

    Google Scholar 

  • 47. Korenchevsky V, Dennison M (1935) Histological changes in organs of rats injected with oestrone and testicular hormone. J Pathol Bacteriol 41: 323-337

    Google Scholar 

  • 48. Kozak J, Bartsch W, Krieg M, Voigt KD (1982) Nuclei of stroma: site of highest estrogen concentration in human prostatic hyperplasia. Prostate 3:433-438

    Google Scholar 

  • 49. Krieg M, Bartsch W, Janssen W, Voigt KD (1979) A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate. J Steroid Biochem 11:615-624

    Google Scholar 

  • 50. Krieg M, Klötzl G, Kaufmann J, Voigt KD (1981) Stroma of human benign prostatic hyperplasia: preferential tissue for androgen metabolism and oestrogen binding. Acta Endocrinol (Copenh) 96:422-432

    Google Scholar 

  • 51. Krieg M, Nass R, Tunn S (1993) Effects of aging on endogenous levels of 5a-dihydrotestosterone, testosterone, estradiol and estrone in epithelium and stroma of normal and hyperplastic human prostate (BPH). J Clin Endocrinol Metab 77: 375-385

    Google Scholar 

  • 52. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sei USA 93: 5925-5930

    Google Scholar 

  • 53. Lahtonen R, Bolton NJ, Konturri M, Vihko R (1983a) Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands. Prostate 4:129-139

    Google Scholar 

  • 54. Lahtonen R, Bolton NJ, Lukkarinen O, Vihko R (1983b) Androgen concentrations in epithelial and stromal cell nuclei of human benign prostatic hypertrophic tissues. J Endocrinol 99:409-414

    Google Scholar 

  • 55. Lieskovsky G, Bruchowsky N (1979) Assay of nuclear androgen receptor in human prostate. J Urol 121:54-58

    Google Scholar 

  • 56. Matzkin H, Soloway MS (1992) Immunhistochemical evidence of the existence and localization of aromatase in human prostatic tissues. Prostate 21: 309-314

    Google Scholar 

  • 57. Meikle WA, Stephenson RA, Lewis, CM, Wiebke GA, Middleton RG (1997) Age, genetic, and nongenetic factors influencing Variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins. Prostate 33:105-111

    Google Scholar 

  • 58. Moore RJ, Wilson JD (1975) Androgen transport and metabolism in the prostate. In: Grayhack JT, Wilson JD, Sherbenske MJ (eds) Benign prostatic hyperplasia. DHEW Publication No (NIH) 76-1113, US Government Printing Office, Washington DC,pp 21-31

    Google Scholar 

  • 59. Moore RJ, Gazak, JM, Wilson JD (1979) Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17ß-estradiol. J Clin Invest 63:351-357

    Google Scholar 

  • 60. Peters CA, Walsh PC (1987) The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist on benign prostatic hyperplasia. N Engl J Med 317: 599-604

    Google Scholar 

  • 61. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endoer Rev 16:271-321

    Google Scholar 

  • 62. Radlmaier A, Eickenberg HU, Fletcher MS, Fourcade RO, Reis Santos JM, van Aubel OG, Bono AV (1996) Estrogen reduetion by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized trial using two doses of the aromatase-inhibitor atamestane. Prostate 29:199-208

    Google Scholar 

  • 63. Rittmaster RS, Norman RW, Thomas LN, Rowden G (1996) Evidence for atrophy and apoptosis in the prostates of men given finasteride. J Clin Endocrinol Metab 81:814-819

    Google Scholar 

  • 64. Röbel P, Eychenne B, Blondeau JP, Baulieu EE, Hechter O (1984) Sex Steroid receptors in normal and hyperplastic prostate In: Bracci U, DiSilvero F (eds) Advances in urological oncology and endocrinology. Acta Medica, Roma, 41-45

    Google Scholar 

  • 65. Romijn JC, Oishi K, Bolt-de Vries J, Schweikert HU, Mulder E, Schröder FH (1980) Androgen metabolism and androgen receptors in separated epithelium and stroma of the human prostate. In: Schröder FH, de Voogt HJ (eds) Steroid receptors, metabolism and prostatic cancer. Excerpta Medica, Amsterdam, pp 134-143

    Google Scholar 

  • 66. Schröder FH, Westerhof M, Bosan RJLH, Kurth KH (1986) Benign prostatic hyperplasia treated by castration or LH-RH analogue busereline: a report on six cases. Eur Urology 12: 318-321

    Google Scholar 

  • 67. Schweikert HU (1979) Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital skin and nongenital skin. Horm Metab Res 11: 635-640

    Google Scholar 

  • 68. Schweikert HU, Tunn UW (1987) Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia. Steroids 50:191-200

    Google Scholar 

  • 69. Schweikert HU, Totzauer P, Rohr HP, Bartsch G (1985) Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia. J Urol 134:403-407

    Google Scholar 

  • 70. Schweikert HU, Neumann F, Tunn UW (1989) Endokrinologische Faktoren für die Entstehung der benignen Prostatahyperplasie. Urologe[A] 28: 317-320

    Google Scholar 

  • 71. Schweikert HU, Tunn UW, Habenicht UF et al. (1993) Effects of estrogen deprivation on human benign prostatic hyperplasia. J Steroid Biochem Molec Biol 44: 573-576

    Google Scholar 

  • 72. Schweikert HU, Weidemann W, Romalo G (1997) Intersexualität: Gonadendysgenesien und Androgenresistenz-Syndrome. Urologe [B] 37:14-23

    Google Scholar 

  • 73. Scott WW, Wade JC (1969) Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate. J Urol 101: 81-85

    Google Scholar 

  • 74. Siiteri PK, Wilson JD (1970) Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest 49:1737-1745

    Google Scholar 

  • 75. Siiteri PK, MacDonald PC (1973) Role of extraglandular estrogen in human endocrinology. In: Handbook of Physiology, section 7, volume II, part I. American Physiological Society, Washington DC,pp 615-629

    Google Scholar 

  • 76. Sirett DAN, Cowan SK, Janecko AE, Grant JK, Glen ES (1980) Prostatic tissue distribution of 17ßhydroxy-5a-androstan-3-one and of androgen receptors in benign hyperplasia. J Steroid Biochem 13:723-728

    Google Scholar 

  • 77. Spindler KD, Schweikert HU, Weidemann W (1998) The human androgen receptor: mutations and diseases. Curr Topics Steroid Res 1: 83-91

    Google Scholar 

  • 78. Stoner E and the Finasteride Study Group (1992) The clinical effects of a 5a-reductase inhibitor, finasteride on benign prostatic hyperplasia. J Urol 147:1298-1302

    Google Scholar 

  • 79. Truss M, Beato M (1993) Steroid receptors: interaction with deoxyribonucleic acid and transcription factors. Endoer Rev 14:459-479

    Google Scholar 

  • 80. Tunn UW, Schüring B, Senge T, Neumann F, Schweikert HU, Rohr HP (1980) Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol and cyproterone acetate. Invest Urol 18:289-292

    Google Scholar 

  • 81. Vermeulen A (1976) Testicular hormonal secretion and aging in males. In: Grayhack JT, Wilson JD, Scherbenske MJ (eds) Benign prostatic hyperplasia. DHEW Publ No. (NIH) 76-1113, US Government Printing Office, Washington, pp 177-182

    Google Scholar 

  • 82. Walsh PC, Wilson JD (1976) The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 57: 1093-1097

    Google Scholar 

  • 83. Walsh PC, Hutchins GM, Ewing LL (1983) Tissue content of dihydrotestosterone in human prostatic hyperplasia is not supranormal. J Clin Invest 72:1772-1777

    Google Scholar 

  • 84. Weidemann W, Linck B, Haupt H et al. (1996) Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clin Endocrinol (Oxf) 45:733-739

    Google Scholar 

  • 85. Wilbert DM, Griffin JE, Wilson JD (1983) Characterization of androgen receptor of the human prostate. J Clin Endocrinol Metab 56:113-120

    Google Scholar 

  • 86. Wilkin RP, Bruchovsky N, Shnitka TK, Rennie PS, Comeau TL (1980) Stromal 5a-reductase activity is elevated in benign prostatic hyperplasia. Acta Endocrinol (Copenh) 94:284-288

    Google Scholar 

  • 87. Wilson JD (1980) The pathogenesis of benign prostatic hyperplasia. Am J Med 68: 745-756

    Google Scholar 

  • 88. Wilson JD, Griffin JE, Russell DW (1993) Steroid 5a-reductase 2 deficiency. Endoer Rev 14: 577-593

    Google Scholar 

  • 1. Abrams P, Feneley RCL (1978) The significance of symptoms associated with bladder outflow obstruction. Urol Int 33:171-174

    Google Scholar 

  • 2. Abrams P, Farras DJ, Turner-Warwick RT, Whiteside CG, Feneley RCL (1979) The results of prostatectomy. A symptomatic and urodynamic analysis of 152 patients. J Urol 121:640-642

    Google Scholar 

  • 3. Abrams P, Griffiths DJ (1979) The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51:129-134

    Google Scholar 

  • 4. Abrams P (1985) Detrusor instability and bladder outlet obstruction. Neurourol Urodyn 4: 317-328

    Google Scholar 

  • 5. Andersen JT, Nordling J (1980) Prostatism II. The correlation between cystourethroscopic, cystometric and urodynamic findings. Scand J Urol Nephrol 14:23-27

    Google Scholar 

  • 6. Andersen JT (1982) Prostatism: clinical radiological and urodynamic aspects. Neurourol Urodyn 1:241-293

    Google Scholar 

  • 7. Andersson KE (1990) Autonomie neurotransmission and the unstable bladder. Neurourol Urodyn: 555-557

    Google Scholar 

  • 8. Barry MJ, Fowler FJ, O’Leary M, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett ATK (1992) The American Urological Association Symptom index for benign prostatic hyperplasia. J Urol 148: 1549-1555

    Google Scholar 

  • 9. Barry MJ, Cockett ATK, Holtgrewe L, McConnell JD, Sihelnik SA, Winfield HN (1993) Relationship of symptoms of prostatism to commonly used physiologic and anatomic measures of the severity of benign prostatic hypertrophy. J Urol 150: 351-358

    Google Scholar 

  • 10. Beck AD (1970) Benign prostatic hypertrophy and uraemia. Br J Surg 57:561-565

    Google Scholar 

  • 11. Bilgen A Wein AJ, Haugaard N, Packard D, Levin RM (1992) Effect of outlet obstruction on pyruvate metabolism of the rabbit urinary bladder. Mol Cell Biochem 117:159-163

    Google Scholar 

  • 12. Birkhoff JD, Wiederhorn AR, Hamilton MC, Zinsser HH (1976) Natural history of benign prostatic hypertrophy and acute urinary retention. Urology 7:48-52

    Google Scholar 

  • 13. Blok C, van Venrooy GEPM, Coolsaet BLRA (1985) Dynamics of the ureterovesical junction effectiveness of ist ureteral peristalsis in high pressure pig bladders. J Urol 134: 825-827

    Google Scholar 

  • 14. Bosch JLHR, Groen J, Schroeder FH (1994) Treatment of benign prostatic hyperplasia by transurethral ultrasound-guided laser-induced prostatectomy (TULIP): effects on urodynamic parameters and symptoms. Urology 44: 507-511

    Google Scholar 

  • 15. Bosch JLHR (1995) Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World J Urol 13:17-20

    Google Scholar 

  • 16. Bosch JLHR, Hop WCJ, Kirkels WJ, Schroeder FH (1995) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual volume. Br J Urol 75: 622-630

    Google Scholar 

  • 17. Bosch JLHR, Kranse R, van Mastrigt R, Schroeder FH (1995) Reasons for weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. J Urol 153: 689-693

    Google Scholar 

  • 18. Bosch R, Kranse R, van Mastrigt R, Schroeder FH (1995) Dependence of male voiding efficiency on age, bladder contractility and urethral resistance: Development of a voiding efficiency nomogram. J Urol 154:190-194

    Google Scholar 

  • 19. Boyarski S, Jones G, Paulson DF, Prout GR (1977) A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy. Trans Amer Ass Genito-Urin Surg 68:19-32

    Google Scholar 

  • 20. Caine M, Perlberg S (1977) The dynamics of acute retention in prostatic patients and the role of adrenergic receptors. Urology 9: 399-403

    Google Scholar 

  • 21. Chai TC, Belville WD, McGuire EJ, Nyquist L (1993) Specificity of American Urological Association voiding Symptom index: comparison of unselected and selected samples of both sexes. J Urol 150:1710-1714

    Google Scholar 

  • 22. Chalfin SA, Bradley WE (1982) The etiology of detrusor hyperreflexia in patients with infravesical obstruction. J Urol 127: 938-942

    Google Scholar 

  • 23. Chancellor MB, Rivas DA (1993) American Urological Association symptom index for women with voiding symptoms: lack of specificity for benign prostatic hyperplasia. J Urol 150:1706-1710

    Google Scholar 

  • 24. Chancellor MB, Rivas DA, Keeley FX, Lofti MA, Gomella LG (1994) Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Br J Urol 74:200-203

    Google Scholar 

  • 25. Chisholm GD (1967) Obstructive uropathy, a review of 146 patients with postrenal uraemia. S Afr Med J 41: 962-964

    Google Scholar 

  • 26. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM (1993) The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150: 85-89

    Google Scholar 

  • 27. Coolsaet BLRA, van Venrooy GEPM, Blok C (1982) Detrusor pressure versus wall stress in relation to ureterovesical resistance. Neurourol Urodyn 1:105-108

    Google Scholar 

  • 28. Coolsaet BLRA, van Duyl WA (1995) Pathophysiology of outlet obstruction. In: Fitzpatrick JM, Krane RJ (eds) The bladder. Churchill Livingstone, Edinburgh London Melbourne New York Tokio, pp 91-117

    Google Scholar 

  • 29. Cucchi A (1990) Detrusor instability in prostatic obstruction in relation to urethral opening pressure. Neurourol Urodyn 9:17-24

    Google Scholar 

  • 30. Diokno AC, Brown MB, Goldstein NG, Herzog AR (1994) Urinary flow rates and voiding pressures in elderly men living in a Community. J Urol 151:1550-1553

    Google Scholar 

  • 31. Elbadawi A, Meyer S (1989) Morphometry of the obstructed detrusor. I. Review of the issues. Neurourol Urodyn 8:163-172

    Google Scholar 

  • 32. Elbadawi A, Miller LF, Yalla SV, Resnick NM (1990) Correlative structural/urodynamic grouping paterns of detrusor abnormality in geriatric voiding dysfunction. Neurourol Urodyn 9:407

    Google Scholar 

  • 33. Elbadawi A (1993) Functional pathology of urinary bladder muscularis: The new frontier in diagnostic uropathology. Sem Diagn Pathol 10: 314-354

    Google Scholar 

  • 34. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol 150:1657-1667

    Google Scholar 

  • 35. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 150:1668-1680

    Google Scholar 

  • 36. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol 150:1681-1695

    Google Scholar 

  • 37. Fall M, Lindström S (1991) Electrical Stimulation. A physiologic approach to the treatment of urinary incontinence. Urol Clin N Am: 18: 393

    Google Scholar 

  • 38. Foster CD, Speakman MJ, Fujii K, Brading A (1989) The effects of chromakalim on the detrusor muscle of human and pig urinary bladder. Br J Urol 63:284-294

    Google Scholar 

  • 39. Fowler FJ, Wennberg JE, Timoth RP, Barry MJ, Mulley AG, Hanley D (1988) Symptom status and quality of life following prostatectomy. JAMA 259: 3018-3022

    Google Scholar 

  • 40. Ghoniem GM (1991) Impaired bladder contractility in association with detrusor instability -underestimated occurence in benign prostatic hyperplasia. Neurourol Urodyn 10:111-118

    Google Scholar 

  • 41. Gilpin SA, Gosling JA Barnard RJ (1985) Morphological and morphometric studies of the human obstructed, trabeculated bladder. Br J Urol 57:525-529

    Google Scholar 

  • 42. Gilpin SA, Gilpin CJ, Dixon JS et al. (1986) The effect of age on the autonomic innervation of the urinary bladder. Br J Urol 58: 378

    Google Scholar 

  • 43. Gleason DM, Bottaccini MR, Byrne JC (1987) Review of current physical and hydrodynamic concepts and their impact on urodynamics. Neurourol Urodyn 6:1-9

    Google Scholar 

  • 44. Gosling JA, Dixon JS (1979) The structure and innervation of trabeculated detrusor smooth muscle. Proc Int Cont Soc 9th Annual Meeting, Rome, pp 9-13

    Google Scholar 

  • 45. Griffiths DJ, van Mastrigt R, van Duyl WA, Coolsaet BLRA (1979) Active mechanical properties of the smooth muscle of the urinary bladder. Med Biol Eng Comput 17:281-290

    Google Scholar 

  • 46. Griffiths DJ (1980) Urodynamics: the mechanics and hydrodynamics of the lower urinary tract. Medical Physics Handbooks 4. Hilger, Bristol

    Google Scholar 

  • 47. Griffiths DJ, Constantinou CE, van Mastrigt R (1986) Urinary bladder function and its control in healthy females. Am J Physiol 251: R225-R230

    Google Scholar 

  • 48. Griffiths DJ, van Mastrigt R, Bosch R (1989) Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia. Neurourol Urodyn 8:17-27

    Google Scholar 

  • 49. Griffiths DJ (1992) Effects of bladder outlet obstruction. Prospectives 2/1:1-4,8

    Google Scholar 

  • 50. Grünewald V, Jonas U (1995) Neurologie abnormalities. In: Fitzpatrick JM, Krane RJ (eds) The bladder. Churchill Livingstone, Edinburgh London Melbourne New York Tokio, pp 195-211

    Google Scholar 

  • 51. Haid T (1989) Urodynamics in benign prostatic hyperplasia. A survey. Prostate [Suppl 2]: 69-77

    Google Scholar 

  • 52. Haid T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walters S (1991) A patient weighted Symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 138: 59-62

    Google Scholar 

  • 53. Haid T, Brading AF, Elbadawi A et al. (1996) Pathology and pathophysiology. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds) Proceedings of the 3rd International Consultation on BPH, Scientific Communication International Ltd, pp 125-166

    Google Scholar 

  • 54. Hill AV (1938) The heat of shortening and the dynamic constants of muscle. Proc R Soc Lond (Biol) 126:136

    Google Scholar 

  • 55. Höfner K (1992) Urodynamic evaluation of lower urinary tract dysfunetion. Current Opinion in Urology 2: 257-262

    Google Scholar 

  • 56. Höfner K, Grünewald V, Kuczyk M, von Dalwig-Nolda D, Jonas U (1993) Influence of transurethral microwave thermotherapy on outflow obstruction. J Endourol 7 [Suppl 1]: 76

    Google Scholar 

  • 57. Höfner K, Kramer AEJL, Kuczyk M, von Dalwig-Nolda D, Krah H, Jonas U (1994) The changes of outflow obstruction and bladder power utilisation after transurethral microwave thermotherapy. J Urol 151 [Suppl]: 417 A

    Google Scholar 

  • 58. Höfner K, Kramer AEJL, Tan HK, Krah H, Jonas U (1995) CHESS Classification of bladder outflow obstruction. A consequence in the discussion of current concepts. World J Urol 13: 59-64

    Google Scholar 

  • 59. Höfner K, Krah H, Gonnermann O, Serth J, Doallo-Kramer S, Plechata B, Jonas U (1996) The relevance of BPH tissue properties in bladder outflow obstruction. J Urol 155 [Suppl]: 380 A

    Google Scholar 

  • 60. Homma Y, Imajo C, Takahashi S, Kawabe K, Azo Y (1994) Urinary symptoms and urodynamics in a normal elderly population. Scand J Urol Nephrol 157 [Suppl]: 27-30

    Google Scholar 

  • 61. Jensen K M-E, Bruskewitz RC, Madsen PO (1984) Urodynamic findings in elderly males without prostatic complaints. Urology 24:211

    Google Scholar 

  • 62. Jensen K M-E, Jorgensen JB, Mogensen P (1988) Urodynamics in prostatism. II. Prognostic value of pressure/flow study combined with stop-test. Scand J Urol Nephrol 114 [Suppl]: 72-77

    Google Scholar 

  • 63. Jonas U, Ogden C, de la Rosette J et al. (1994) Symptom score and flow rate: independent parameters in clinical response to microwave thermotherapy. J Urol 151 [Suppl]: 326 A

    Google Scholar 

  • 64. Jones DA, Gilpin DA, Holden D, Dixon JS, O’Reilly PH, Georges NJR (1991) Relationship between bladder morphology and long term outcome of treatment in patients with high pressure chronic retention of urine. Br J Urol 67: 280-285

    Google Scholar 

  • 65. Jones DA, Georges NRJ (1992) Interactive obstructive uropathy in man. Br J Urol 69: 337-345

    Google Scholar 

  • 66. Kaplan SA, Te AE, Pressler LB, Olsson CA (1995) Transition zone index (TZI) as a method of assessing benign prostatic hyperplasia: correlation with symptoms, uroflow and and detrusor pressure. J Urol 154:1764-1769

    Google Scholar 

  • 67. Kato K, Lin AT-L, Wein AJ, Levin RM (1990) Effect of outlet obstruction on glucose metabolism of the rabbit urinary bladder. J Urol 143: 844-847

    Google Scholar 

  • 68. Kato K, Wein AJ, Longhurst PA et al. (1990) The functional effects of long-term outlet obstruction on the rabbit urinary bladder. J Urol 143: 600-606

    Google Scholar 

  • 69. Kirby RS, Coppinger SWC, Corcoran MO, Chapple CR, Flannigan M, Milroy EJG (1987) Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Br J Urol 60:136-142

    Google Scholar 

  • 70. Kirkland JL, Lye M, Levy DW, Banerjee AK (1983) Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J 287:1665-1667

    Google Scholar 

  • 71. Ko DS, Fenster HN, Chambers K, Sullivan LD, Jens M, Goldenberg SL (1995) The correlation of multichannel urodynamic pressure-flow studies and American Urological Association Symptom Index in the evaluation of benign prostatic hyperplasia. J Urol 154: 396-398

    Google Scholar 

  • 72. Kranse M, van Mastrigt R (1991) The derivation of an obstruction index from a three parameter model fitted to the lowest part of the pressure flow plot. J Urol 145: 261 A

    Google Scholar 

  • 73. Lepor H, Machi G (1993) Comparison of AUA Symptom index in unselected males and females between fifty-five and seventy years of age. Urology 42: 36-41

    Google Scholar 

  • 74. Levin RM, Longhurst PA, Wein AJ (1990) Neuropharmacologic investigations of the lower urinary tract. World J Urol 8:180-188

    Google Scholar 

  • 75. Lim CS, Abrams P (1995) The Abrams-Griffiths nomogram. World J Urol 13: 34-39

    Google Scholar 

  • 76. Lin AT-L, Chang LS, Chen M-S, Yang C-H, Shiao M-S, Chen C-J, Levin RM (1992) Energetics of detrusor contraction: effects of outlet obstruction. Neurourol Urodyn 11: 605-614

    Google Scholar 

  • 77. Lindström S, Fall M, Carlsson CA, Erlandson BE (1984): Rhythmic activity in pelvic efferents to the bladder: an experimental study in the cat with reference to the clinical condition »unstable bladder«. Urol Int 39: 272

    Google Scholar 

  • 78. Lutzeyer W, Hannapel J, Schäfer W (1983) Sequential events in prostatic obstruction. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 693-699

    Google Scholar 

  • 79. Madsen PO, Iversen P (1983) A point system for selecting operative candidates. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 763-765

    Google Scholar 

  • 80. Mark SD, Gilling PJ,van Mastrigt R, Arnold EP, Mcrae CU (1992) detrusor contractility: age related correlation with urinary flow rate in asymptomatic males. Neurourol Urodyn 11: 314-315

    Google Scholar 

  • 81. Martorana G, Giberti C, Disilverio F et al. (1995) Urodynamic assessment of alfuzosin on outflow obstruction in benign prostatic hyperplasia. J Urol 153: 275 A

    Google Scholar 

  • 82. Mayo ME, Lloyd-Davies RW, Shuttlewort KED, Tighe JR (1973) The damaged human detrusor: functional and electronmicroscopic changes in disease. Br J Urol 45:116-120

    Google Scholar 

  • 83. McConnell JD (1995) Benign prostatic hyperplasia: treatment guidelines and patient Classification. Br J Urol 76 [Suppl 1]: 29-46

    Google Scholar 

  • 84. Mebust W, Roizo R, Shroeder F, Villers A (1992) Correlations between pathology, clinical symptoms and the course of the disease. In: Cockett ATK, Aso Y, Chatelain C, Denis L, Griffiths K, Khoury S, Murphy G (eds) Proceedings of the Ist International Consultation on BPH, Scientific Communication International Ltd, Jersey, pp 53-62

    Google Scholar 

  • 85. Meyer S, Atta MA, Wein AJ, Levin RM, Elbadawi A (1989) Morphometric analysis of muscle cell changes in the short term partially obstructed rabbit detrusor. Neurourol Urodyn 8: 117-131

    Google Scholar 

  • 86. Meyer S, Elbadawi A (1989) Morphometry of the obstructed detrusor. II. Principles of a comprehensive protocol. Neurourol Urodyn 8:173-191

    Google Scholar 

  • 87. Moon TD, Brannan W, Stone NN et al. (1994) Effect of age, educational status, ethnicity and geographic location on prostate Symptom scores. J Urol 152:1498-1500

    Google Scholar 

  • 88. Neal DE, Ramsden PD, Sharples L, Powell PH, Styles RA, Webb RJ (1989) Outcome of elective prostatectomy. Br Med J 299: 762-767

    Google Scholar 

  • 89. Nitti VW, Kim Y, Combs AJ (1994) Correlation of the AUA Symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn 13: 521-529

    Google Scholar 

  • 90. Parys BT, Machin DG, Woolfenden KA, Parsons KF (1988) chronic urinary retention - a sensory problem? Br J Urol 62: 546-549

    Google Scholar 

  • 91. Perlberg S, Caine M (1982) Adrenergic response of bladder muscle in prostatic obstruction. Urology 20: 524-537

    Google Scholar 

  • 92. Puppo P, Perachino M, Bozzo W, Vitali A, Ardoino S, Ferro MA (1992) Does thermotherapy induce a long term alpha blockade? An immunohistochemical study. Europ Urol Proc Xth Congress of the European Assoc of Urology, p 195

    Google Scholar 

  • 93. Resnick NM, Yalla SV (1987) Detrusor hyperactivity with impaired contractile function. JAMA 257: 3076-3081

    Google Scholar 

  • 94. Restorick JM, Mundy AR (1989) The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyperreflexic human detrusor. Br J Urol 63: 32-35

    Google Scholar 

  • 95. Reynard J, Abrams P (1994) Symptoms and symptom scores in BPH. Scand J Urol Nephrol 157 [Suppl]: 137-145

    Google Scholar 

  • 96. Robertson AS, Airey R, Griffiths CJ, Sharles L, Neal DE (1993) Detrusor contraction strength in men undergoing prostatectomy. Neurourol Urodyn 12:109-122

    Google Scholar 

  • 97. Rollema HJ, van Mastrigt R (1992) Improved indication and follow-up in transurethral resection of the prostate (TUR) using the Computer program CLIM. J Urol 148:111-116

    Google Scholar 

  • 98. Rosier PF WM, Rollema HJ, van den Beek C, Janknegt RA (1992) Diagnosis of »prostatism«; relation between symptoms and urodynamic evaluation of obstruction and bladder function. Neurourol Urodyn 11: 399-400

    Google Scholar 

  • 99. Rosier PFWM, de la Rosette JJMCH (1995) Is there a correlation between prostate size and bladder outlet obstruction? World J Urol 13:9-13

    Google Scholar 

  • 100. Schäfer W (1983) Detrusor as the energy source of micturition. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 450-469

    Google Scholar 

  • 101. Schäfer W (1983) The contribution of the bladder outlet to the relation between pressure and flow rate during micturition. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 470-496

    Google Scholar 

  • 102. Schäfer W (1985) Urethral resistance? Urodynamic concepts of physiological and pathological bladder outlet function during voiding. Neurourol Urodyn 4:161-201

    Google Scholar 

  • 103. Schäfer W (1990) Basic principles and clinical application of advanced analysis of bladder voiding function. Urol Clin N Am 17:553-566

    Google Scholar 

  • 104. Schäfer W (1991) Analysis of active detrusor function during voiding with the bladder working function. Neurourol Urodyn 10:19-35

    Google Scholar 

  • 105. Schäfer W (1995) Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease specific approach for grading obstruction: from complex to simple. World J Urol 13:47-58

    Google Scholar 

  • 106. Sehn JT (1979) The ultrastructural effect of distension on the neuromuscular apparatus of the urinary bladder. Invest Urol 16:369-375

    Google Scholar 

  • 107. Sibley GNA (1987) The physiological response of the detrusor muscle to experimental bladder outflow obstruction in the pig. Br J Urol 60:332-336

    Google Scholar 

  • 108. Smith JB, Pierce JM (1983) The development of vesical trabeculation. In: Hinman F Jr (ed) Benign prostatic hypertrophy. Springer, Berlin Heidelberg New York, pp 682-688

    Google Scholar 

  • 109. Spängberg A, Terio H, Ask P, Engberg A (1991) Pressure/flow studies preoperatively and postoperatively in patients with benign prostatic hypertrophy: estimation of the urethral pressure/ flow relation and urethral elasticity. Neurourol Urodyn 10:139-167

    Google Scholar 

  • 110. Speakman MJ, Brading AF, Gilpin CJ, Dixon JS, Gilpin SA, Gosling JA (1987) Bladder outflow obstruction: a cause of denervation supersensitivity. J Urol 138:1461-1466

    Google Scholar 

  • 111. Speakman MJ, Brading AF, Dixon JS, Gilpin SA, Gilpin CJ, Gosling JA (1991) Cystometric, physiological and morphological studies after relief of bladder outflow obstruction in the pig. Br J Urol 68:243-247

    Google Scholar 

  • 112. Strehler BL (1986) Time, cells and aging. Academic Press, New York, pp 1-456

    Google Scholar 

  • 113. Tan HK, Höfner K, Kramer AEJL, Thon WF, Grünewald V, Jonas U (1993) Benign prostatic hypertrophy (BPH): prostatic size, obstruction parameters, detrusor contractility and their interdependence. Neurourol Urodyn 12:412-413

    Google Scholar 

  • 114. Tan HK, Höfner K, Kramer AEJL, Grünewald V, Jonas U (1994) Correlations between ICS- and Boyarski symptom scores and mechanical outflow obstruction in BPH patients. J Urol 151 [Suppl]: 272 A

    Google Scholar 

  • 115. Turner-Warwick R et al. (1973) A urodynamic view of prostatic obstruction and the results of prostatectomy. Br J Urol 45:631-645

    Google Scholar 

  • 116. van den Beek C, Rollema HJ, Boender H, Wolfs GGMC, Knottnerus JA, Janknegt RA (1993) Relationship between AUA symptom score and objective pressure flow parameters. Neurourol Urodyn 12: 369-370

    Google Scholar 

  • 117. van Mastrigt R (1992) Age dependence of urinary bladder contractility. Neurourol Urodyn 11: 315-317

    Google Scholar 

  • 118. van Venrooj GE, Boon TA, de Gier RP (1995) International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 153:1516-1519

    Google Scholar 

  • 119. Yalla SV, Sullivan MP, Lecamwasam HS, DuBeau CE, Vickers MA, Cravalho EG (1995) Correlation of American Urological Association Symptom Index with obstructive and nonobstructive prostatism. J Urol 153:674-679

    Google Scholar 

  • 120. Zhao, Y, Wein Aj, Bilgen A, Levin RM (1992) The effect of anoxia on in vitro bladder function. Pharmacology 43: 337-344.

    Google Scholar 

Download references

Authors
  1. V. Grünewald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Helpap
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Jonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H.-U. Schweikert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. W. Tunn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Urologische Klinik, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Klaus Höfner , Udo Jonas  & Christian G. Stief ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grünewald, V., Helpap, B., Jonas, U., Schweikert, HU., Tunn, U.W. (2000). Pathophysiologie. In: Höfner, K., Jonas, U., Stief, C.G. (eds) Benigne Prostatahyperplasie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59580-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59580-6_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64034-6

  • Online ISBN: 978-3-642-59580-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation